Eiger BioPharmaceuticals (EIGR)

9.51 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/13/18 *Est.)

Latest Headlines

Form 8-K Eiger BioPharmaceuticals For: Jun 15 June 17, 2020 5:09 PM - SEC Filing Eiger BioPharma (EIGR) PT Raised to $23 at Citi June 5, 2020 6:17 AM - StreetInsider Eiger BioPharma (EIGR) PT Raised to $34 at Wedbush June 4, 2020 3:28 PM - StreetInsider Form DEFA14A Eiger BioPharmaceuticals May 29, 2020 4:19 PM - SEC Filing Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020 May 29, 2020 4:05 PM - PR NewsWire Eiger to Present at Jefferies Virtual Healthcare Conference 2020 May 26, 2020 4:05 PM - PR NewsWire Form 8-K Eiger BioPharmaceuticals For: May 19 May 19, 2020 4:11 PM - SEC Filing Eiger BioPharmaceuticals (EIGR) Reports FDA Acceptance of NDA Filing with Priority Review of Zokinvy (lonafarnib) for Treatment of Progeria & Progeroid Laminopathies May 19, 2020 4:11 PM - StreetInsider Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvyâ„¢ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies May 19, 2020 4:05 PM - PR NewsWire Form 10-Q Eiger BioPharmaceuticals For: Mar 31 May 7, 2020 4:21 PM - SEC Filing Form 8-K Eiger BioPharmaceuticals For: May 07 May 7, 2020 4:11 PM - SEC Filing Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update May 7, 2020 4:06 PM - PR NewsWire Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda April 30, 2020 8:00 AM - PR NewsWire Form DEFA14A Eiger BioPharmaceuticals April 28, 2020 4:36 PM - SEC Filing Form DEF 14A Eiger BioPharmaceuticals For: Jun 10 April 28, 2020 4:35 PM - SEC Filing Eiger BioPharmaceuticals (EIGR) Reports EMA Validation of Lonafarnib MAA for Treatment of Progeria & Progeroid Laminopathies April 27, 2020 8:08 AM - StreetInsider Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies April 27, 2020 8:00 AM - PR NewsWire Full Article List